Benjamin F. Edwards & Company’s Elevance Health ELV Stock Holding History

Benjamin F. Edwards & Company’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$26.9M	Sell	49,666 -362	-0.7%	-$191K	0.47%	60
2024 Q1	$25.9M	Buy	50,028 +2,314	+5%	+$1.15M	0.47%	57
2023 Q4	$22.5M	Buy	47,714 +46,619	+4,257%	+$21.6M	0.45%	66
2023 Q3	$477K	Buy	1,095 +660	+152%	+$299K	0.02%	531
2023 Q2	$193K	Sell	435 -202	-32%	-$93.2K	0.01%	745
2023 Q1	$293K	Buy	637 +5	+0.8%	+$2.38K	0.01%	609
2022 Q4	$324K	Sell	632 -50	-7%	-$25.4K	0.01%	580
2022 Q3	$310K	Buy	682 +5	+0.7%	+$2.39K	0.02%	548
2022 Q2	$327K	Sell	677 -72	-10%	-$35.6K	0.02%	535
2022 Q1	$368K	Sell	749 -9	-1%	-$4.11K	0.02%	523
2021 Q4	$352K	Buy	758 +201	+36%	+$84.6K	0.02%	535
2021 Q3	$208K	Sell	557 -4	-0.7%	-$1.52K	0.01%	644
2021 Q2	$214K	Buy	561 +64	+13%	+$24.5K	0.01%	634
2021 Q1	$178K	Hold	497	–	–	0.01%	705
2020 Q4	$160K	Hold	497	–	–	0.01%	698
2020 Q3	$133K	Sell	497 -3	-0.6%	-$807	0.01%	685
2020 Q2	$131K	Hold	500	–	–	0.01%	666
2020 Q1	$114K	Hold	500	–	–	0.01%	654
2019 Q4	$151K	Hold	500	–	–	0.01%	680
2019 Q3	$120K	Sell	500 -3	-0.6%	-$822	0.01%	692
2019 Q2	$142K	Sell	503 -5	-1%	-$1.37K	0.01%	611
2019 Q1	$146K	Buy	508 +8	+2%	+$2.31K	0.01%	574
2018 Q4	$131K	Buy	500 +200	+67%	+$55K	0.01%	586
2018 Q3	$82K	Sell	300 -30	-9%	-$7.79K	0.01%	737
2018 Q2	$79K	Buy	330 +30	+10%	+$6.95K	0.01%	740
2018 Q1	$66K	Hold	300	–	–	0.01%	775
2017 Q4	$68K	Hold	300	–	–	0.01%	738
2017 Q3	$57K	Hold	300	–	–	0.01%	739
2017 Q2	$56K	Hold	300	–	–	0.01%	689
2017 Q1	$50K	Hold	300	–	–	0.01%	672
2016 Q4	$43K	Hold	300	–	–	0.01%	639
2016 Q3	$38K	Hold	300	–	–	0.01%	584
2016 Q2	$39K	Hold	300	–	–	0.01%	556
2016 Q1	$42K	Hold	300	–	–	0.01%	542
2015 Q4	$42K	Hold	300	–	–	0.01%	549
2015 Q3	$42K	Hold	300	–	–	0.01%	564
2015 Q2	$49K	Hold	300	–	–	0.01%	601
2015 Q1	$46K	Hold	300	–	–	0.01%	580
2014 Q4	$38K	Hold	300	–	–	0.01%	568
2014 Q3	$36K	Hold	300	–	–	0.01%	555
2014 Q2	$32K	Hold	300	–	–	0.01%	533
2014 Q1	$30K	Hold	300	–	–	0.01%	518
2013 Q4	$28K	Hold	300	–	–	0.01%	500
2013 Q3	$25K	Hold	300	–	–	0.01%	480
2013 Q2	$25K	Buy	+300	New	+$22.5K	0.01%	441

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Benjamin F. Edwards & Company's ELV Position: Q2 2024 in Review

Benjamin F. Edwards & Company reduced its Elevance Health (ELV) stake by 0.72% in Q2 2024, selling an estimated $191K and leaving 49,666 shares worth $26.9M. The position accounts for 0.47% of the portfolio, ranked #60.

Benjamin F. Edwards & Company first reported a position in ELV in Q2 2013 and has held it in 45 quarters since. 1,706 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

Benjamin F. Edwards & Company held 49,666 shares of Elevance Health worth $26.9M as of Q2 2024.
Benjamin F. Edwards & Company sold 362 Elevance Health shares in Q2 2024, an estimated $191K.
Elevance Health made up 0.47% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #60 holding.
Benjamin F. Edwards & Company first reported a position in Elevance Health in Q2 2013 and has held it in 45 quarters since.
1,706 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.